Parallax Health Sciences Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was USD 25,855 compared to USD 990 a year ago. Operating loss was USD 1.916 million compared to USD 2.121 million a year ago. Net loss was USD 2.460 million compared to net income of USD 25.074 million a year ago. Basic loss per share from continuing operations was USD 0.011 compared to basic earnings per share from continuing operations of USD 0.167 a year ago. Diluted loss per share from continuing operations was USD 0.009 compared to diluted earnings per share from continuing operations of USD 0.12 a year ago. For the nine months, sales was USD 77,745 compared to USD 10,749 a year ago. Operating loss was USD 5.138 million compared to USD 5.257 million a year ago. Net loss was USD 6.458 million compared to net income of USD 17.255 million a year ago. Basic loss per share from continuing operations was USD 0.034 compared to basic earnings per share from continuing operations of USD 0.124 a year ago. Diluted loss per share from continuing operations was USD 0.028 compared to diluted earnings per share from continuing operations of USD 0.088 a year ago.